Biping Deng

2.4k total citations
64 papers, 1.1k citations indexed

About

Biping Deng is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Biping Deng has authored 64 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 13 papers in Molecular Biology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Biping Deng's work include CAR-T cell therapy research (45 papers), Lymphoma Diagnosis and Treatment (9 papers) and Virus-based gene therapy research (7 papers). Biping Deng is often cited by papers focused on CAR-T cell therapy research (45 papers), Lymphoma Diagnosis and Treatment (9 papers) and Virus-based gene therapy research (7 papers). Biping Deng collaborates with scholars based in China, United States and Switzerland. Biping Deng's co-authors include Jing Pan, Xun Qu, Alex H. Chang, Tong Wu, Zhuojun Ling, Chunrong Tong, Yuehui Lin, Shuangyou Liu, Haiting Mao and Zhichao Yin and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Biping Deng

58 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Biping Deng China 17 775 287 283 229 164 64 1.1k
Enkhtsetseg Purev United States 21 755 1.0× 768 2.7× 308 1.1× 168 0.7× 101 0.6× 55 1.6k
Si Li China 16 707 0.9× 362 1.3× 265 0.9× 117 0.5× 201 1.2× 51 1.1k
Xiaojian Zhu China 18 426 0.5× 535 1.9× 163 0.6× 99 0.4× 92 0.6× 68 959
Francis Mussai United Kingdom 18 510 0.7× 438 1.5× 591 2.1× 128 0.6× 93 0.6× 40 1.4k
Yunxin Lai China 9 504 0.7× 227 0.8× 250 0.9× 101 0.4× 175 1.1× 10 779
Robert A. Preti United States 13 220 0.3× 289 1.0× 98 0.3× 117 0.5× 116 0.7× 32 898
Larry D. Anderson United States 23 832 1.1× 658 2.3× 339 1.2× 114 0.5× 108 0.7× 92 1.4k
Carmen S. Yong Australia 12 1.2k 1.5× 455 1.6× 848 3.0× 313 1.4× 303 1.8× 21 1.7k
Htoo Zarni Oo Canada 21 453 0.6× 743 2.6× 121 0.4× 82 0.4× 72 0.4× 54 1.2k
Dongli Yue China 20 728 0.9× 533 1.9× 619 2.2× 75 0.3× 83 0.5× 41 1.4k

Countries citing papers authored by Biping Deng

Since Specialization
Citations

This map shows the geographic impact of Biping Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biping Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biping Deng more than expected).

Fields of papers citing papers by Biping Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Biping Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biping Deng. The network helps show where Biping Deng may publish in the future.

Co-authorship network of co-authors of Biping Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Biping Deng. A scholar is included among the top collaborators of Biping Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Biping Deng. Biping Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Fei, Rui Liu, Fan Yang, et al.. (2025). CD20CAR-T Therapy Preemptively Treats Patients with Relapsed/Refractory DLBCL in Partial Remission after CD19CAR-T. Transplantation and Cellular Therapy. 31(11). 889–897.
2.
Xue, Fei, Rui Liu, Fan Yang, et al.. (2025). Sequential CD19-20 CAR T-cell therapy for refractory/relapsed diffuse large B-cell lymphoma. Cytotherapy. 27(8). 910–916.
3.
Dou, Yimeng, Rui Liu, Fan Yang, et al.. (2025). Efficacy and Safety of CART Cell Therapy in Aggressive B‐Cell Lymphomas Involving the Gastrointestinal Tract. Cancer Reports. 8(1). e70083–e70083.
4.
Pan, Jing, Liping Zhao, Samuel Seery, et al.. (2025). Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial. Blood. 146(23). 2745–2757. 1 indexed citations
5.
6.
Deng, Biping, Zhaoli Liu, Xiaoming Qu, et al.. (2024). Different T-Cell Activation Approaches Impact the Resulting CART-Cell Products and Possible Clinical Outcomes. Blood. 144(Supplement 1). 4856–4856. 2 indexed citations
7.
Lin, Yuehui, Defeng Zhao, Biping Deng, et al.. (2024). The Safety and Efficacy of CD33 CAR-T Therapy for RR AML after HSCT. Blood. 144(Supplement 1). 3467–3467. 4 indexed citations
8.
Liu, Rui, Fan Yang, Biping Deng, et al.. (2024). Utilizing BTK Inhibitors for Maintenance and Long-Term Control Following CAR-T Cell Therapy in B-Cell Non-Hodgkin Lymphoma. Blood. 144(Supplement 1). 6183–6183. 1 indexed citations
9.
Xue, Fei, Fan Yang, Rui Liu, et al.. (2024). Salvage CD20-SD-CART therapy in aggressive B-cell lymphoma after CD19 CART treatment failure. Frontiers in Oncology. 14. 1376490–1376490. 2 indexed citations
10.
11.
Tan, Yue, Liping Zhao, Biping Deng, et al.. (2023). Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia. Journal of Hematology & Oncology. 16(1). 34–34. 49 indexed citations
12.
Deng, Biping, Jing Pan, Zhaoli Liu, et al.. (2021). Peripheral leukemia burden at time of apheresis negatively affects the clinical efficacy of CART19 in refractory or relapsed B-ALL. Molecular Therapy — Methods & Clinical Development. 23. 633–643. 10 indexed citations
13.
Pan, Jing, Jieyu Yang, Biping Deng, et al.. (2017). High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients. Leukemia. 31(12). 2587–2593. 172 indexed citations
14.
Deng, Biping, Yun-Sik Yang, Haiting Mao, et al.. (2012). Soluble BAFF-R produced by decidual stromal cells plays an inhibitory role in monocytes and macrophages. Reproductive BioMedicine Online. 24(6). 654–663. 8 indexed citations
15.
Jia, Lin, Hui Zhang, Xun Qu, Biping Deng, & Beihua Kong. (2012). Proteomic analysis reflects different histologic subtypes of epithelial ovarian cancer. Medical Hypotheses. 78(3). 407–409. 4 indexed citations
16.
Mao, Haiting, Lining Zhang, Yongmei Yang, et al.. (2011). RhoBTB2 (DBC2) functions as tumor suppressor via inhibiting proliferation, preventing colony formation and inducing apoptosis in breast cancer cells. Gene. 486(1-2). 74–80. 25 indexed citations
17.
Mao, Haiting, Yuhong Yang, Yujing Bi, et al.. (2010). New Insights of CTLA-4 into Its Biological Function in Breast Cancer. Current Cancer Drug Targets. 10(7). 728–736. 83 indexed citations
18.
Sun, Jintang, Yan Zhang, Meixiang Yang, et al.. (2009). Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: the role of adenosine receptor A2. Cellular and Molecular Immunology. 7(1). 77–82. 48 indexed citations
19.
Mao, Haiting, Xun Qu, Yongmei Yang, et al.. (2009). A novel tumor suppressor gene RhoBTB2 (DBC2): Frequent loss of expression in sporadic breast cancer. Molecular Carcinogenesis. 49(3). 283–289. 16 indexed citations
20.
Zhang, Hui, Beihua Kong, Xun Qu, et al.. (2006). Biomarker discovery for ovarian cancer using SELDI-TOF-MS. Gynecologic Oncology. 102(1). 61–66. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enkhtsetseg Purev Breakdown of academic impact, for papers by Si Li Breakdown of academic impact, for papers by Xiaojian Zhu Breakdown of academic impact, for papers by Francis Mussai Breakdown of academic impact, for papers by Yunxin Lai Breakdown of academic impact, for papers by Robert A. Preti Breakdown of academic impact, for papers by Larry D. Anderson Breakdown of academic impact, for papers by Carmen S. Yong Breakdown of academic impact, for papers by Htoo Zarni Oo Breakdown of academic impact, for papers by Dongli Yue
Rankless by CCL
2026